Last updated on August 2019

Study of NaQuinate in Healthy Volunteers


Brief description of study

Phase 1, randomised, double-blind, placebo-controlled study of NaQuinate in healthy subjects after single ascending oral (PO) doses and multiple ascending PO doses.

Detailed Study Description

This first-in-human (FIH) clinical study is a Phase 1, randomised, double-blind, placebo-controlled study to assess the safety, tolerability, and PK of NaQuinate in healthy subjects after single ascending oral (PO) doses and multiple ascending PO doses.

Clinical Study Identifier: NCT04036617

Find a site near you

Start Over